OBJECTIVE: Little is known about the progression of cognitive deficits in older, community-dwelling patients with schizophrenia, especially in comparison to healthy subjects. METHOD: The authors examined the relationship of age to performance on the Mattis Dementia Rating Scale in 116 outpatients with schizophrenia and 122 normal comparison subjects. Subjects ranged in age from 40 to 85 years. RESULTS: Dementia Rating Scale scores were lower in the schizophrenia group but correlated negatively with age in both groups, with no significant differences seen between the schizophrenia and normal comparison groups in slopes that depicted age-related variation. CONCLUSIONS: This cross-sectional study suggests a relatively stable long-term course of cognitive impairment in individuals with schizophrenia, with no evidence of faster cognitive decline in outpatients with schizophrenia than in normal comparison subjects.
OBJECTIVE: Little is known about the progression of cognitive deficits in older, community-dwelling patients with schizophrenia, especially in comparison to healthy subjects. METHOD: The authors examined the relationship of age to performance on the Mattis Dementia Rating Scale in 116 outpatients with schizophrenia and 122 normal comparison subjects. Subjects ranged in age from 40 to 85 years. RESULTS: Dementia Rating Scale scores were lower in the schizophrenia group but correlated negatively with age in both groups, with no significant differences seen between the schizophrenia and normal comparison groups in slopes that depicted age-related variation. CONCLUSIONS: This cross-sectional study suggests a relatively stable long-term course of cognitive impairment in individuals with schizophrenia, with no evidence of faster cognitive decline in outpatients with schizophrenia than in normal comparison subjects.
Authors: Brian H Shirts; Konasale M Prasad; Michael F Pogue-Geile; Faith Dickerson; Robert H Yolken; Vishwajit L Nimgaonkar Journal: Schizophr Res Date: 2008-09-17 Impact factor: 4.939
Authors: Javier Olivera; Sergio Benabarre; Teófilo Lorente; Mariano Rodriguez; Alfonso Barros; Carmen Quintana; Virtudes Pelegrina; Carmen Aldea Journal: Ment Health Fam Med Date: 2011-03
Authors: Mario Fioravanti; Olimpia Carlone; Barbara Vitale; Maria Elena Cinti; Linda Clare Journal: Neuropsychol Rev Date: 2005-06 Impact factor: 7.444
Authors: V S Gabrovska-Johnson; M Scott; S Jeffries; N Thacker; R C Baldwin; A Burns; S W Lewis; J F W Deakin Journal: Psychopharmacology (Berl) Date: 2003-07-04 Impact factor: 4.530
Authors: Wesley K Thompson; Gauri N Savla; Ipsit V Vahia; Colin A Depp; Ruth O'Hara; Dilip V Jeste; Barton W Palmer Journal: Schizophr Res Date: 2012-12-05 Impact factor: 4.939
Authors: Tarek K Rajji; Aristotle N Voineskos; Meryl A Butters; Dielle Miranda; Tamara Arenovich; Mahesh Menon; Zahinoor Ismail; Robert S Kern; Benoit H Mulsant Journal: Am J Geriatr Psychiatry Date: 2013-01-22 Impact factor: 4.105